nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.215	0.379	CbGbCtD
Lomefloxacin—CYP1A2—Pentoxifylline—systemic scleroderma	0.136	0.24	CbGbCtD
Lomefloxacin—CYP1A2—Leflunomide—systemic scleroderma	0.13	0.229	CbGbCtD
Lomefloxacin—ABCC2—Methotrexate—systemic scleroderma	0.0861	0.152	CbGbCtD
Lomefloxacin—TOP2A—Methyltestosterone—Prednisone—systemic scleroderma	0.0011	1	CbGdCrCtD
Lomefloxacin—Confusional state—Lisinopril—systemic scleroderma	0.000329	0.000761	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000329	0.00076	CcSEcCtD
Lomefloxacin—Headache—Mometasone—systemic scleroderma	0.000329	0.00076	CcSEcCtD
Lomefloxacin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000759	CcSEcCtD
Lomefloxacin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000328	0.000757	CcSEcCtD
Lomefloxacin—Fatigue—Leflunomide—systemic scleroderma	0.000328	0.000757	CcSEcCtD
Lomefloxacin—Oedema—Lisinopril—systemic scleroderma	0.000327	0.000754	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000327	0.000754	CcSEcCtD
Lomefloxacin—Pruritus—Captopril—systemic scleroderma	0.000326	0.000754	CcSEcCtD
Lomefloxacin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000326	0.000752	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000751	CcSEcCtD
Lomefloxacin—Constipation—Leflunomide—systemic scleroderma	0.000325	0.000751	CcSEcCtD
Lomefloxacin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000324	0.000748	CcSEcCtD
Lomefloxacin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000323	0.000747	CcSEcCtD
Lomefloxacin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000322	0.000744	CcSEcCtD
Lomefloxacin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000322	0.000744	CcSEcCtD
Lomefloxacin—Shock—Lisinopril—systemic scleroderma	0.000321	0.000742	CcSEcCtD
Lomefloxacin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00074	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00032	0.000739	CcSEcCtD
Lomefloxacin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000319	0.000737	CcSEcCtD
Lomefloxacin—Tachycardia—Lisinopril—systemic scleroderma	0.000319	0.000736	CcSEcCtD
Lomefloxacin—Abdominal pain—Azathioprine—systemic scleroderma	0.000318	0.000735	CcSEcCtD
Lomefloxacin—Skin disorder—Lisinopril—systemic scleroderma	0.000317	0.000733	CcSEcCtD
Lomefloxacin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000316	0.00073	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000316	0.000729	CcSEcCtD
Lomefloxacin—Diarrhoea—Captopril—systemic scleroderma	0.000315	0.000729	CcSEcCtD
Lomefloxacin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000315	0.000728	CcSEcCtD
Lomefloxacin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000728	CcSEcCtD
Lomefloxacin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000314	0.000726	CcSEcCtD
Lomefloxacin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000314	0.000725	CcSEcCtD
Lomefloxacin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000313	0.000723	CcSEcCtD
Lomefloxacin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000313	0.000722	CcSEcCtD
Lomefloxacin—Nausea—Mometasone—systemic scleroderma	0.000312	0.00072	CcSEcCtD
Lomefloxacin—Anorexia—Lisinopril—systemic scleroderma	0.000311	0.000719	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000311	0.000718	CcSEcCtD
Lomefloxacin—Ataxia—Methotrexate—systemic scleroderma	0.00031	0.000716	CcSEcCtD
Lomefloxacin—Constipation—Mycophenolic acid—systemic scleroderma	0.00031	0.000716	CcSEcCtD
Lomefloxacin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000308	0.000712	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Prednisone—systemic scleroderma	0.000308	0.000711	CcSEcCtD
Lomefloxacin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000707	CcSEcCtD
Lomefloxacin—Hypotension—Lisinopril—systemic scleroderma	0.000305	0.000705	CcSEcCtD
Lomefloxacin—Dizziness—Captopril—systemic scleroderma	0.000305	0.000704	CcSEcCtD
Lomefloxacin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000702	CcSEcCtD
Lomefloxacin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000699	CcSEcCtD
Lomefloxacin—Urticaria—Leflunomide—systemic scleroderma	0.000302	0.000697	CcSEcCtD
Lomefloxacin—Abdominal pain—Leflunomide—systemic scleroderma	0.0003	0.000694	CcSEcCtD
Lomefloxacin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.0003	0.000692	CcSEcCtD
Lomefloxacin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000299	0.00069	CcSEcCtD
Lomefloxacin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000689	CcSEcCtD
Lomefloxacin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000689	CcSEcCtD
Lomefloxacin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000689	CcSEcCtD
Lomefloxacin—Myocardial infarction—Prednisone—systemic scleroderma	0.000298	0.000689	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000298	0.000689	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000297	0.000687	CcSEcCtD
Lomefloxacin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000687	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000297	0.000686	CcSEcCtD
Lomefloxacin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000296	0.000685	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000296	0.000685	CcSEcCtD
Lomefloxacin—Insomnia—Lisinopril—systemic scleroderma	0.000295	0.000682	CcSEcCtD
Lomefloxacin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000295	0.000681	CcSEcCtD
Lomefloxacin—Paraesthesia—Lisinopril—systemic scleroderma	0.000293	0.000677	CcSEcCtD
Lomefloxacin—Vomiting—Captopril—systemic scleroderma	0.000293	0.000677	CcSEcCtD
Lomefloxacin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000674	CcSEcCtD
Lomefloxacin—Dyspnoea—Lisinopril—systemic scleroderma	0.000291	0.000672	CcSEcCtD
Lomefloxacin—Rash—Captopril—systemic scleroderma	0.000291	0.000672	CcSEcCtD
Lomefloxacin—Dermatitis—Captopril—systemic scleroderma	0.00029	0.000671	CcSEcCtD
Lomefloxacin—Somnolence—Lisinopril—systemic scleroderma	0.00029	0.000671	CcSEcCtD
Lomefloxacin—Headache—Captopril—systemic scleroderma	0.000289	0.000667	CcSEcCtD
Lomefloxacin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000288	0.000666	CcSEcCtD
Lomefloxacin—Dyspepsia—Lisinopril—systemic scleroderma	0.000287	0.000664	CcSEcCtD
Lomefloxacin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000287	0.000662	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000661	CcSEcCtD
Lomefloxacin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000661	CcSEcCtD
Lomefloxacin—Decreased appetite—Lisinopril—systemic scleroderma	0.000284	0.000656	CcSEcCtD
Lomefloxacin—Eosinophilia—Methotrexate—systemic scleroderma	0.000282	0.000652	CcSEcCtD
Lomefloxacin—Fatigue—Lisinopril—systemic scleroderma	0.000282	0.00065	CcSEcCtD
Lomefloxacin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000281	0.00065	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000647	CcSEcCtD
Lomefloxacin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00028	0.000647	CcSEcCtD
Lomefloxacin—Constipation—Lisinopril—systemic scleroderma	0.000279	0.000645	CcSEcCtD
Lomefloxacin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000645	CcSEcCtD
Lomefloxacin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000642	CcSEcCtD
Lomefloxacin—Bradycardia—Prednisone—systemic scleroderma	0.000278	0.000642	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000639	CcSEcCtD
Lomefloxacin—Diarrhoea—Azathioprine—systemic scleroderma	0.000275	0.000636	CcSEcCtD
Lomefloxacin—Nausea—Captopril—systemic scleroderma	0.000274	0.000633	CcSEcCtD
Lomefloxacin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000273	0.00063	CcSEcCtD
Lomefloxacin—Asthenia—Leflunomide—systemic scleroderma	0.000273	0.00063	CcSEcCtD
Lomefloxacin—Hallucination—Prednisone—systemic scleroderma	0.000272	0.000627	CcSEcCtD
Lomefloxacin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000269	0.000622	CcSEcCtD
Lomefloxacin—Pruritus—Leflunomide—systemic scleroderma	0.000269	0.000621	CcSEcCtD
Lomefloxacin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000618	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000267	0.000617	CcSEcCtD
Lomefloxacin—Dysuria—Methotrexate—systemic scleroderma	0.000266	0.000616	CcSEcCtD
Lomefloxacin—Dizziness—Azathioprine—systemic scleroderma	0.000266	0.000615	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000602	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00026	0.000601	CcSEcCtD
Lomefloxacin—Asthenia—Mycophenolic acid—systemic scleroderma	0.00026	0.000601	CcSEcCtD
Lomefloxacin—Diarrhoea—Leflunomide—systemic scleroderma	0.00026	0.000601	CcSEcCtD
Lomefloxacin—Urticaria—Lisinopril—systemic scleroderma	0.000259	0.000599	CcSEcCtD
Lomefloxacin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000598	CcSEcCtD
Lomefloxacin—Abdominal pain—Lisinopril—systemic scleroderma	0.000258	0.000596	CcSEcCtD
Lomefloxacin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000593	CcSEcCtD
Lomefloxacin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000256	0.000592	CcSEcCtD
Lomefloxacin—Vomiting—Azathioprine—systemic scleroderma	0.000256	0.000591	CcSEcCtD
Lomefloxacin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000589	CcSEcCtD
Lomefloxacin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000588	CcSEcCtD
Lomefloxacin—Rash—Azathioprine—systemic scleroderma	0.000254	0.000586	CcSEcCtD
Lomefloxacin—Dermatitis—Azathioprine—systemic scleroderma	0.000253	0.000586	CcSEcCtD
Lomefloxacin—Flushing—Prednisone—systemic scleroderma	0.000253	0.000585	CcSEcCtD
Lomefloxacin—Headache—Azathioprine—systemic scleroderma	0.000252	0.000582	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000252	0.000582	CcSEcCtD
Lomefloxacin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000582	CcSEcCtD
Lomefloxacin—Dizziness—Leflunomide—systemic scleroderma	0.000251	0.00058	CcSEcCtD
Lomefloxacin—Renal failure—Methotrexate—systemic scleroderma	0.00025	0.000577	CcSEcCtD
Lomefloxacin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000575	CcSEcCtD
Lomefloxacin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000248	0.000573	CcSEcCtD
Lomefloxacin—Stomatitis—Methotrexate—systemic scleroderma	0.000248	0.000572	CcSEcCtD
Lomefloxacin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000247	0.000571	CcSEcCtD
Lomefloxacin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000565	CcSEcCtD
Lomefloxacin—Arrhythmia—Prednisone—systemic scleroderma	0.000244	0.000563	CcSEcCtD
Lomefloxacin—Haematuria—Methotrexate—systemic scleroderma	0.000242	0.00056	CcSEcCtD
Lomefloxacin—Vomiting—Leflunomide—systemic scleroderma	0.000242	0.000558	CcSEcCtD
Lomefloxacin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000241	0.000556	CcSEcCtD
Lomefloxacin—Dizziness—Mycophenolic acid—systemic scleroderma	0.00024	0.000554	CcSEcCtD
Lomefloxacin—Epistaxis—Methotrexate—systemic scleroderma	0.00024	0.000554	CcSEcCtD
Lomefloxacin—Rash—Leflunomide—systemic scleroderma	0.00024	0.000553	CcSEcCtD
Lomefloxacin—Dermatitis—Leflunomide—systemic scleroderma	0.000239	0.000553	CcSEcCtD
Lomefloxacin—Nausea—Azathioprine—systemic scleroderma	0.000239	0.000552	CcSEcCtD
Lomefloxacin—Headache—Leflunomide—systemic scleroderma	0.000238	0.00055	CcSEcCtD
Lomefloxacin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000237	0.000548	CcSEcCtD
Lomefloxacin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000545	CcSEcCtD
Lomefloxacin—Asthenia—Lisinopril—systemic scleroderma	0.000234	0.000541	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000234	0.00054	CcSEcCtD
Lomefloxacin—Pruritus—Lisinopril—systemic scleroderma	0.000231	0.000534	CcSEcCtD
Lomefloxacin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00023	0.000532	CcSEcCtD
Lomefloxacin—Rash—Mycophenolic acid—systemic scleroderma	0.000229	0.000528	CcSEcCtD
Lomefloxacin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000228	0.000528	CcSEcCtD
Lomefloxacin—Hepatitis—Methotrexate—systemic scleroderma	0.000228	0.000527	CcSEcCtD
Lomefloxacin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000525	CcSEcCtD
Lomefloxacin—Headache—Mycophenolic acid—systemic scleroderma	0.000227	0.000525	CcSEcCtD
Lomefloxacin—Pharyngitis—Methotrexate—systemic scleroderma	0.000226	0.000523	CcSEcCtD
Lomefloxacin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000522	CcSEcCtD
Lomefloxacin—Nausea—Leflunomide—systemic scleroderma	0.000226	0.000521	CcSEcCtD
Lomefloxacin—Diarrhoea—Lisinopril—systemic scleroderma	0.000223	0.000516	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Prednisone—systemic scleroderma	0.00022	0.000509	CcSEcCtD
Lomefloxacin—Visual impairment—Methotrexate—systemic scleroderma	0.00022	0.000508	CcSEcCtD
Lomefloxacin—Anaemia—Prednisone—systemic scleroderma	0.00022	0.000507	CcSEcCtD
Lomefloxacin—Agitation—Prednisone—systemic scleroderma	0.000218	0.000504	CcSEcCtD
Lomefloxacin—Angioedema—Prednisone—systemic scleroderma	0.000217	0.000502	CcSEcCtD
Lomefloxacin—Dizziness—Lisinopril—systemic scleroderma	0.000216	0.000499	CcSEcCtD
Lomefloxacin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000216	0.000498	CcSEcCtD
Lomefloxacin—Nausea—Mycophenolic acid—systemic scleroderma	0.000215	0.000497	CcSEcCtD
Lomefloxacin—Malaise—Prednisone—systemic scleroderma	0.000214	0.000495	CcSEcCtD
Lomefloxacin—Vertigo—Prednisone—systemic scleroderma	0.000213	0.000493	CcSEcCtD
Lomefloxacin—Syncope—Prednisone—systemic scleroderma	0.000213	0.000492	CcSEcCtD
Lomefloxacin—Tinnitus—Methotrexate—systemic scleroderma	0.000213	0.000491	CcSEcCtD
Lomefloxacin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000487	CcSEcCtD
Lomefloxacin—Loss of consciousness—Prednisone—systemic scleroderma	0.000209	0.000482	CcSEcCtD
Lomefloxacin—Vomiting—Lisinopril—systemic scleroderma	0.000208	0.00048	CcSEcCtD
Lomefloxacin—Rash—Lisinopril—systemic scleroderma	0.000206	0.000476	CcSEcCtD
Lomefloxacin—Convulsion—Prednisone—systemic scleroderma	0.000206	0.000476	CcSEcCtD
Lomefloxacin—Dermatitis—Lisinopril—systemic scleroderma	0.000206	0.000475	CcSEcCtD
Lomefloxacin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000474	CcSEcCtD
Lomefloxacin—Hypertension—Prednisone—systemic scleroderma	0.000205	0.000474	CcSEcCtD
Lomefloxacin—Chills—Methotrexate—systemic scleroderma	0.000205	0.000473	CcSEcCtD
Lomefloxacin—Headache—Lisinopril—systemic scleroderma	0.000205	0.000473	CcSEcCtD
Lomefloxacin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000468	CcSEcCtD
Lomefloxacin—Arthralgia—Prednisone—systemic scleroderma	0.000202	0.000467	CcSEcCtD
Lomefloxacin—Myalgia—Prednisone—systemic scleroderma	0.000202	0.000467	CcSEcCtD
Lomefloxacin—Anxiety—Prednisone—systemic scleroderma	0.000202	0.000466	CcSEcCtD
Lomefloxacin—Discomfort—Prednisone—systemic scleroderma	0.0002	0.000462	CcSEcCtD
Lomefloxacin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000452	CcSEcCtD
Lomefloxacin—Dysgeusia—Methotrexate—systemic scleroderma	0.000194	0.000449	CcSEcCtD
Lomefloxacin—Nausea—Lisinopril—systemic scleroderma	0.000194	0.000448	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000194	0.000448	CcSEcCtD
Lomefloxacin—Oedema—Prednisone—systemic scleroderma	0.000194	0.000448	CcSEcCtD
Lomefloxacin—Back pain—Methotrexate—systemic scleroderma	0.000192	0.000444	CcSEcCtD
Lomefloxacin—Shock—Prednisone—systemic scleroderma	0.000191	0.000441	CcSEcCtD
Lomefloxacin—Tachycardia—Prednisone—systemic scleroderma	0.000189	0.000437	CcSEcCtD
Lomefloxacin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000437	CcSEcCtD
Lomefloxacin—Skin disorder—Prednisone—systemic scleroderma	0.000188	0.000435	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000187	0.000433	CcSEcCtD
Lomefloxacin—Anorexia—Prednisone—systemic scleroderma	0.000185	0.000427	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000184	0.000426	CcSEcCtD
Lomefloxacin—Anaemia—Methotrexate—systemic scleroderma	0.000184	0.000424	CcSEcCtD
Lomefloxacin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000182	0.00042	CcSEcCtD
Lomefloxacin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000417	CcSEcCtD
Lomefloxacin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000416	CcSEcCtD
Lomefloxacin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000414	CcSEcCtD
Lomefloxacin—Malaise—Methotrexate—systemic scleroderma	0.000179	0.000414	CcSEcCtD
Lomefloxacin—Vertigo—Methotrexate—systemic scleroderma	0.000178	0.000412	CcSEcCtD
Lomefloxacin—Leukopenia—Methotrexate—systemic scleroderma	0.000178	0.000411	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000177	0.000408	CcSEcCtD
Lomefloxacin—Insomnia—Prednisone—systemic scleroderma	0.000175	0.000405	CcSEcCtD
Lomefloxacin—Paraesthesia—Prednisone—systemic scleroderma	0.000174	0.000402	CcSEcCtD
Lomefloxacin—Cough—Methotrexate—systemic scleroderma	0.000173	0.0004	CcSEcCtD
Lomefloxacin—Convulsion—Methotrexate—systemic scleroderma	0.000172	0.000397	CcSEcCtD
Lomefloxacin—Dyspepsia—Prednisone—systemic scleroderma	0.000171	0.000394	CcSEcCtD
Lomefloxacin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000393	CcSEcCtD
Lomefloxacin—Chest pain—Methotrexate—systemic scleroderma	0.000169	0.000391	CcSEcCtD
Lomefloxacin—Arthralgia—Methotrexate—systemic scleroderma	0.000169	0.000391	CcSEcCtD
Lomefloxacin—Myalgia—Methotrexate—systemic scleroderma	0.000169	0.000391	CcSEcCtD
Lomefloxacin—Decreased appetite—Prednisone—systemic scleroderma	0.000169	0.000389	CcSEcCtD
Lomefloxacin—Fatigue—Prednisone—systemic scleroderma	0.000167	0.000386	CcSEcCtD
Lomefloxacin—Discomfort—Methotrexate—systemic scleroderma	0.000167	0.000386	CcSEcCtD
Lomefloxacin—Constipation—Prednisone—systemic scleroderma	0.000166	0.000383	CcSEcCtD
Lomefloxacin—Confusional state—Methotrexate—systemic scleroderma	0.000163	0.000377	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000162	0.000374	CcSEcCtD
Lomefloxacin—Feeling abnormal—Prednisone—systemic scleroderma	0.00016	0.000369	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000159	0.000367	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000159	0.000366	CcSEcCtD
Lomefloxacin—Skin disorder—Methotrexate—systemic scleroderma	0.000157	0.000364	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000157	0.000362	CcSEcCtD
Lomefloxacin—Anorexia—Methotrexate—systemic scleroderma	0.000154	0.000357	CcSEcCtD
Lomefloxacin—Urticaria—Prednisone—systemic scleroderma	0.000154	0.000356	CcSEcCtD
Lomefloxacin—Abdominal pain—Prednisone—systemic scleroderma	0.000153	0.000354	CcSEcCtD
Lomefloxacin—Hypotension—Methotrexate—systemic scleroderma	0.000151	0.00035	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000148	0.000341	CcSEcCtD
Lomefloxacin—Insomnia—Methotrexate—systemic scleroderma	0.000147	0.000339	CcSEcCtD
Lomefloxacin—Paraesthesia—Methotrexate—systemic scleroderma	0.000146	0.000336	CcSEcCtD
Lomefloxacin—Dyspnoea—Methotrexate—systemic scleroderma	0.000144	0.000334	CcSEcCtD
Lomefloxacin—Somnolence—Methotrexate—systemic scleroderma	0.000144	0.000333	CcSEcCtD
Lomefloxacin—Hypersensitivity—Prednisone—systemic scleroderma	0.000143	0.00033	CcSEcCtD
Lomefloxacin—Dyspepsia—Methotrexate—systemic scleroderma	0.000143	0.00033	CcSEcCtD
Lomefloxacin—Decreased appetite—Methotrexate—systemic scleroderma	0.000141	0.000325	CcSEcCtD
Lomefloxacin—Fatigue—Methotrexate—systemic scleroderma	0.00014	0.000323	CcSEcCtD
Lomefloxacin—Asthenia—Prednisone—systemic scleroderma	0.000139	0.000321	CcSEcCtD
Lomefloxacin—Pruritus—Prednisone—systemic scleroderma	0.000137	0.000317	CcSEcCtD
Lomefloxacin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000134	0.000309	CcSEcCtD
Lomefloxacin—Diarrhoea—Prednisone—systemic scleroderma	0.000133	0.000307	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000133	0.000306	CcSEcCtD
Lomefloxacin—Urticaria—Methotrexate—systemic scleroderma	0.000129	0.000297	CcSEcCtD
Lomefloxacin—Dizziness—Prednisone—systemic scleroderma	0.000128	0.000296	CcSEcCtD
Lomefloxacin—Abdominal pain—Methotrexate—systemic scleroderma	0.000128	0.000296	CcSEcCtD
Lomefloxacin—Vomiting—Prednisone—systemic scleroderma	0.000123	0.000285	CcSEcCtD
Lomefloxacin—Rash—Prednisone—systemic scleroderma	0.000122	0.000282	CcSEcCtD
Lomefloxacin—Dermatitis—Prednisone—systemic scleroderma	0.000122	0.000282	CcSEcCtD
Lomefloxacin—Headache—Prednisone—systemic scleroderma	0.000121	0.000281	CcSEcCtD
Lomefloxacin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000119	0.000276	CcSEcCtD
Lomefloxacin—Asthenia—Methotrexate—systemic scleroderma	0.000116	0.000269	CcSEcCtD
Lomefloxacin—Nausea—Prednisone—systemic scleroderma	0.000115	0.000266	CcSEcCtD
Lomefloxacin—Pruritus—Methotrexate—systemic scleroderma	0.000115	0.000265	CcSEcCtD
Lomefloxacin—Diarrhoea—Methotrexate—systemic scleroderma	0.000111	0.000256	CcSEcCtD
Lomefloxacin—Dizziness—Methotrexate—systemic scleroderma	0.000107	0.000248	CcSEcCtD
Lomefloxacin—Vomiting—Methotrexate—systemic scleroderma	0.000103	0.000238	CcSEcCtD
Lomefloxacin—Rash—Methotrexate—systemic scleroderma	0.000102	0.000236	CcSEcCtD
Lomefloxacin—Dermatitis—Methotrexate—systemic scleroderma	0.000102	0.000236	CcSEcCtD
Lomefloxacin—Headache—Methotrexate—systemic scleroderma	0.000102	0.000235	CcSEcCtD
Lomefloxacin—Nausea—Methotrexate—systemic scleroderma	9.63e-05	0.000222	CcSEcCtD
